GC Aesthetics is pleased to announce the appointment of Mr. Larry Chen as “GCA APAC General Manager”.
Larry has over 20 years of experience in the medical device industry occupying different key roles as Marketing, Sales and General Manager positions in APAC. He delivered outstanding results working with international medical device companies such as Stryker, Johnson & Johnson Medical, Smith & Nephew, based both in the USA and China, with increasing responsibilities for both China and around Asia Pacific region. More recently he led the successful AsiaPac launch and expansion at Zipline as APAC Director.
Larry holds an MBA (Master in Business and Administration) at University of Leuven, Belgium and college degree in Beijing, China. He knows how to deal with customers on the ground in Asia, understands the western culture and expectations.
We sat down with Larry to ask him some questions;
Why did you decide to join GC Aesthetics?
I am familiar with this business segment and the scope due to 6 years+ experience in another plastic surgery focused company in the region of Asia Pac, both in sales development role, strategic market & professional education activities. So, this seems a natural fit. It is also a first to be part of a European based business.
What do you find interesting about General Manager Asia Pacific?
This is a dynamic region, with diverse culture, various level of development. It is also a leading growth engine for healthcare/ medical device industry.
What do you consider the biggest challenges and opportunities?
Regulation is definitely one, as plastic surgery devices are highly regulated, Asia being more stringent without uniform standard/ process. We still need to bring a more complete portfolio to the market. Secondly compared to the last few years, we can do more to have brand recognition and educational exchanges, with in-country management and build more capabilities in the region. Thirdly we could also leverage more in-region presence to improve distribution coverage. The largest market potential are in China, Korea and Thailand.